Cancer immunotherapy – converting immune failure to clinical response

In 2013, cancer immunotherapy was selected as breakthrough of the year by the journal Science. After decades of disappointment with therapeutic vaccines that were by and large ineffective (Klebanoff et al., 2011; Rosenberg et al., 2004), it is now clear that current immunotherapeutic strategies can cure patients, even when conventional therapy is insufficient. The tide has changed, but why and how?

Source: Molecular Oncology - October 29, 2015 Category: Cancer & Oncology Authors: Johanna Olweus Tags: Editorial Source Type: research